>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead
AGGRASTAT (tirofiban HCl).
December 18, 2014
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue Read more
November 5, 2014
Dr. Albert Friesen To File Early Warning Report Read more
October 16, 2014
Medicure Reports Financial Results For The First Quarter Fiscal 2015 Read more
Sign up to receive email updates such as Press Release nofications and other company news.